The company is awaiting regulatory approvals for its mRNA vaccine for Covid-19. (Representational image) India’s first mRNA-based Covid-19 vaccine, from Gennova Biopharma, a subsidiary of Pune-based Emcure Pharmaceuticals, is in its final stages. Soumya Swaminathan, chief scientist at the World Health Organization (WHO), visited Gennova’s vaccine manufacturing facility at Hinjewadi in Pune on Monday. The … Read more
Sanjay Singh, CEO of Gennova Biopharmaceuticals, said after establishing the safety of the mRNA-based Covid-19 vaccine candidate HGCO19 in Phase I clinical trial, the company would start Phase II/III clinical trial. Gennova Biopharmaceuticals on Tuesday received approval from the Drugs Controller General of India (DCGI) to start Phase II/III trials for its Covid-19 vaccine. Gennova … Read more
Gennova Biopharmaceutical’s vaccine candidate is the first mRNA-based vaccine to be produced in India. (Representative Image, IE) After Covaxin and Covishield, now Pune-based drugmaker firm, Gennova Biopharmaceuticals is all set to start early to mid-stage human trials of its Covid-19 vaccine, HGCO19. The trials will start ‘’soon’’ and around 620 people will be enrolled for … Read more